|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-bearing deposits in banks | ||||||||||||||||||||
| Federal funds and other short-term investments | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Trading securities | ||||||||||||||||||||
| Debt securities available-for-sale | ||||||||||||||||||||
| Debt securities held-to-maturity (fair value $1,848,900 and $1,918,426, respectively) | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Mortgage loans held for sale | ||||||||||||||||||||
| Equipment financing receivables held for sale | ||||||||||||||||||||
| Loans and leases held for investment | ||||||||||||||||||||
| Less allowance for credit losses - loans and leases | ||||||||||||||||||||
| Loans and leases, net | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Bank-owned life insurance | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Net deferred tax asset | ||||||||||||||||||||
| Derivative financial instruments | ||||||||||||||||||||
| Goodwill and other intangible assets, net | ||||||||||||||||||||
| Other assets (including $100,421 and $107,583 at fair value, respectively) | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Noninterest-bearing demand | ||||||||||||||||||||
| Interest-bearing deposits | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||||
| Federal Home Loan Bank advances | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Derivative financial instruments | ||||||||||||||||||||
| Accrued expense and other liabilities (including $68,210 and $69,482 at fair value, respectively) | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders' equity: | ||||||||||||||||||||
| Preferred stock, $1 par value: 10,000,000 shares authorized; 0 and 3,662 Series I issued and outstanding; $25,000 per share liquidation preference | ||||||||||||||||||||
| Common stock, $1 par value: 200,000,000 shares authorized, 119,763,827 and 120,598,266 shares issued and outstanding, respectively | ||||||||||||||||||||
| Common stock issuable: 608,291 and 600,168 shares, respectively | ||||||||||||||||||||
| Capital surplus | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||||||
| Common Stock, Shares Authorized | ||||||||||||||||||||
| Preferred stock, issued (in shares) |
Loading...
